Investigators led by Tanya Simuni, MD, the Arthur C. Nielsen, Jr., Research Professor of Parkinson's Disease and Movement ...

Holiday shopping and gift-giving can often be challenging, but even more so if you’re shopping for a person living with dementia. There are nearly 7 million Americans living with Alzheimer’s ...

Cassava Sciences Inc.’s stock tumbled 85% Monday to put it on track for its biggest-ever one-day decline, after the clinical-stage biotech company said a trial of a treatment for mild to moderate ...

Cassava Sciences Inc.’s stock crated 85% in premarket trade Monday, after the clinical-stage biotech said a trial of a treatment for mild-to-moderate Alzheimer’s disease failed to meet its main goals.

People with Alzheimer's exhibit a loss of motor control along with cognitive decline, and one of the earliest signs of this decay can be spotted in involuntary eye movements known as saccades. These ...

Alzheimer's disease affects more than 50 million people worldwide, often devastating both the individuals who have it and ...

Alzheimer’s disease affects roughly six million Americans ... critical biomarker for Alzheimer’s diagnosis and progression tracking. These tests have been proven to be as accurate and ...

A quick finger prick and a few drops of blood on a card that can be sent in regular mail. This approach could soon make Alzheimer's testing much more accessible worldwide.

My eldest sister has asked me to take on her power of attorney for her, and together we met with her attorney.” ...

"We took careful measures to enroll patients with mild-to-moderate [Alzheimer's disease]," Chief Executive Rick Barry said in prepared remarks. "Despite that, the loss of cognition in the placebo ...

It is critical to recognise dementia early on since it can improve care and quality of life for individuals affected. However ...

A breakthrough in the fight against Alzheimer’s disease may have been made in Seattle. Researchers at the Allen Institute ...